Abiopharma

News list

Director Watson Lucas E 🟢 acquired 12 shares (1 derivative) of W.W. GRAINGER, INC. (GWW) Transaction Date: Sep 01, 2026 | Filing ID: 000007

Full text

News bot Sept. 1, 2026, 9:37 p.m.
🔍 Watson Lucas E (Director)

Company: W.W. GRAINGER, INC. (GWW)

Report Date: 2026-09-01
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 1
- Total shares acquired: 12
- Total shares held: 157
Detailed Transactions and Holdings:
- Holds 0 shares of Common Stock (Direct)
  Date: 2026-09-01 | Code: H | nature_of_ownership: Held in the Watson Trust. | shares_owned_after: 157.00 | Footnotes: F1
- Acquired 12 shares of Deferred Stock Units (Derivative)
  Date: 2026-09-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 6,023.00 | transaction_form_type: 4 | Footnotes: F2, F3, F3
Footnotes:
- F1: Held in the Lucas E. Watson Trust -2025, of which the reporting person is the trustee.
- F2: 1-for-1
- F3: The deferred stock units are expected to settle in shares of common stock on a one-for-one basis following end of service as a director.